548 Avsnitt

  1. Leveraging Technology to Empower Patients and Decentralize Clinical Trials

    Publicerades: 2022-10-20
  2. Equipping The Next-Generation Rare Disease Patient Advocate

    Publicerades: 2022-10-13
  3. How a Family Raced from Diagnosis to Experimental Gene Therapy in Three Years

    Publicerades: 2022-10-06
  4. How One Advocate Went from Losing His Hearing to Being Heard

    Publicerades: 2022-09-29
  5. Building a Pipeline of Therapies to Treat Rare Mineralization Disorders

    Publicerades: 2022-09-22
  6. Advancing an Oral Alternative to Infused and Injected Therapies for HAE

    Publicerades: 2022-09-15
  7. Embracing the Promise of Patient-Centered Biotechnology

    Publicerades: 2022-09-08
  8. Learning to Live with Loss

    Publicerades: 2022-09-01
  9. Using Cryptocurrency to Tap into the Wisdom of Crowds

    Publicerades: 2022-08-25
  10. A Therapy for a Rare Neurodegenerative Disease Moves Towards Regulatory Review

    Publicerades: 2022-08-18
  11. Transforming the Treatment of Neuromuscular Diseases with Next-Gen Oligonucleotides

    Publicerades: 2022-08-11
  12. Teaching the Immune System to Let Medicines Do Their Job

    Publicerades: 2022-08-04
  13. Designing Clinical Trials with the Patient in Mind

    Publicerades: 2022-07-28
  14. Keeping Clinical Trials Running Smoothly

    Publicerades: 2022-07-21
  15. A Vision for Patient-Centric Gene Therapy Development

    Publicerades: 2022-07-14
  16. Using Genetic Testing to Address Disparities in Care for Kidney Disease

    Publicerades: 2022-07-07
  17. Why Reforms to the Accelerated Approval Pathway Threaten Rare Disease Drug Development

    Publicerades: 2022-06-30
  18. A Longstanding Academic-Nonprofit Collaboration Gives Rise to an ALS Drug Company

    Publicerades: 2022-06-16
  19. Targeting Regulatory RNA to Upregulate Gene Expression to Treat Rare Diseases

    Publicerades: 2022-06-09
  20. Developing a New Approach to Treat Rare, Autoimmune Conditions

    Publicerades: 2022-06-02

8 / 28

RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.

Visit the podcast's native language site